SCHEMBL4455933

SCHEMBL4455933

CCC(O)CNI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18412654 0.79
SCHEMBL1719873 0.79
SCHEMBL21040066 0.79
SCHEMBL10613218 0.78
Water SCHEMBL1741352 0.77
SCHEMBL19006514 0.75
SCHEMBL588144 0.75 KDM4E (0.46)
SCHEMBL10612986 0.74
SCHEMBL23072787 0.73 KDM4E (0.36)
SCHEMBL9142081 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3206782-B1 CONTROLLED RELEASE DUAL WALLED MICROCAPSULES PROCTER & GAMBLE (US) 2021-12-15 EP disclosed
US-11110050-B2 Hair styling method and kit thereof WELLA OPERATIONS US, LLC (US) 2021-09-07 US disclosed
EP-3172302-B1 FABRIC AND HOME CARE TREATMENT COMPOSITIONS PROCTER & GAMBLE (US) 2019-01-16 EP disclosed
EP-2552400-B1 COMPOSITION COMPRISING MODIFIED ORGANOSILICONES PROCTER & GAMBLE (US) 2018-02-21 EP disclosed
US-20090220454-A1 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy PHARMACYCLICS, INC. (US) 2009-09-03 US disclosed
US-20070192968-A1 Colorants for keratin fibers PROCTER & GAMBLE COMPANY, THE 2007-08-23 US disclosed
EP-0143371-B1 PROCESS FOR THE OPTICAL RESOLUTION OF RACEMIC MIXTURES OF ALPHA-NAPHTHYL-PROPIONIC ACIDS ALFA CHEM ITAL (IT) 1988-02-24 EP disclosed